奈米技术药物传输市场：按技术、按应用、按最终用户、按地区

全球奈米技术药物输送市场预计到2024年将达到971亿美元，预计到2031年将达到2032.1亿美元，2024年至2031年的复合年增长率为11.1%。

图：2024 年按地区分類的奈米技术药物输送市场占有率(%)

基于奈米技术的药物传输解决了药物研究和开发中的许多挑战。透过促进治疗标靶化和控制递送，奈米技术提高了药物有效负载的溶解度、稳定性和生物有效性。人们已经研究了各种奈米载体，包括脂质体、聚合物奈米颗粒、无机奈米颗粒和树状聚合物，它们封装药物分子并将其有效转运至体内目标位点的能力。材料工程和表面功能化方面正在进行的研究可以优化这些奈米载体，以实现最佳的药物动力学和生物分布曲线。全球奈米技术药物传输市场可能会成长，因为该领域将尖端研究转化为安全有效的医疗解决方案。

市场动态：

全球奈米技术药物输送市场的成长是由奈米载体克服传统药物传递的许多限制的能力所推动的。奈米载体可以增加难溶性药物的溶解度并保护治疗有效负载不被降解，从而提高生物有效性。由于渗透性和保留性增强，奈米载体的小尺寸允许被动靶向肿瘤部位。使用表面配体的主动靶向可以帮助将高浓度的药物特异性输送到患病细胞，同时避免对健康组织的毒性。然而，奈米载体设计的复杂性、高研究成本以及有关长期安全性和毒性评估的监管挑战等因素可能会阻碍市场成长。多功能奈米载体的采用和持续的材料优化可能会提供新的机会来开发针对以前无法治疗的标靶的治疗方法并将应用扩展到新的疾病领域。

本研究的主要特点

• 该报告对全球奈米技术药物输送市场进行了详细分析，并以2023年为基准年估计了预测期内（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。发表。
• 它揭示了各个细分市场的潜在商机，并说明了该市场中有吸引力的投资提案的矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
• 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球奈米技术药物输送市场的主要企业。
• 该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
• 全球奈米技术药物输送市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 相关人员可以透过用于全球奈米技术药物传输市场分析的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

• 研究目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• 一致的机会地图 (COM)

第三章 市场动态、法规与趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 影响分析
• 市场趋势
• 监管场景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第四章全球奈米技术药物传输市场 - 冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 对市场的影响

第五章 全球奈米科技药物输送市场，依科技划分，2019-2031 年（十亿美元）

• 介绍
• 奈米粒子
• 奈米悬浮液
• 脂质体
• 胶束
• 其他的

第六章 2019-2031 年全球奈米技术药物传输市场（按应用划分）（十亿美元）

• 介绍
• 肿瘤学和血液学
• 感染疾病
• 整形外科
• 神经病学
• 泌尿系统
• 免疫学
• 其他的

第七章 全球奈米科技药物输送市场，依最终用户划分，2019-2031 年（十亿美元）

• 介绍
• 医院/诊所
• 生物製药公司
• 研究机构/研究所
• 其他的

第八章全球奈米技术药物传输市场，按地区，2019-2031（十亿美元）

• 介绍
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东

第9章 竞争格局

• 公司简介
  • AbbVie Inc.
  • Geistlich Pharma AG
  • Alkermes plc
  • Amgen Inc.
  • AngioDynamics Inc.
  • Arrowhead Pharmaceuticals Inc.
  • BIND Therapeutics Inc.
  • Capsulution Nanoscience AG
  • Celgene Corporation
  • Johnson &Johnson
  • Nanobiotix
  • Nanocarrier Co. Ltd.
  • Merck &Co. Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi SA
  • SkyePharma PLC
  • Starpharma Holdings Limited
  • Teva Pharmaceutical Industries Ltd.

第10章分析师建议

• 上升和下降
• 综合机会图

第十一章 参考文献与调查方法

• 参考
• 调查方法

Global nanotechnology drug delivery market is estimated to be valued at USD 97.10 Bn in 2024 and is expected to reach USD 203.21 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 11.1% from 2024 to 2031.

Figure. Nanotechnology Drug Delivery Market Share (%), By Region 2024

Nanotechnology-based drug delivery address many challenges in pharmaceutical research and development. By facilitating targeted and controlled delivery of therapeutic agents, nanotechnology improves the solubility, stability and bioavailability of drug payloads. Various nanocarriers such as liposomes, polymeric nanoparticles, inorganic nanoparticles and dendrimers are being investigated for their ability to encapsulate drug molecules and transport them efficiently to target sites in the body. Ongoing research in material engineering and surface functionalization can optimize these nanocarriers for achieving optimal pharmacokinetic and biodistribution profiles. Global nanotechnology drug delivery market can witness growth as this field translates cutting-edge research into safe and effective medical solutions.

Market Dynamics:

Global nanotechnology drug delivery market growth is driven by the ability of nanocarriers to overcome many limitations of conventional drug delivery. Nanocarriers can enhance solubility of poorly soluble drugs and protect therapeutic payloads from degradation, thus, improving bioavailability. Their small size enables achievement of passive targeting to tumor sites via enhanced permeability and retention effect. Active targeting using surface ligands helps to deliver high drug concentrations specifically to diseased cells while avoiding toxicity to healthy tissues. However, factors such as complexity of nanocarrier design, high research costs, and regulatory challenges related to long-term safety and toxicity assessment can hamper the market growth. The introduction of multifunctional nanocarriers and continuing material optimization can offer new opportunities to develop therapeutics for previously undruggable targets and expand applications to newer disease areas.

Key features of the study:

• This report provides in-depth analysis of the global nanotechnology drug delivery market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global nanotechnology drug delivery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Pfizer, Johnson & Johnson, AbbVie, Novartis, and Amgen
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global nanotechnology drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nanotechnology drug delivery market

Detailed Segmentation-

• By Technology
  • Nanoparticles
  • Nano suspensions
  • Liposomes
  • Micelles
  • Others
• By Application
  • Oncology and Hematology
  • Infectious diseases
  • Orthopedics
  • Neurology
  • Urology
  • Immunology
  • Others
• By End User
  • Hospitals & Clinics
  • Biopharmaceutical Companies
  • Research Institutes & Laboratories
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • AbbVie Inc.
  • Geistlich Pharma AG
  • Alkermes plc
  • Amgen Inc.
  • AngioDynamics Inc.
  • Arrowhead Pharmaceuticals Inc.
  • BIND Therapeutics Inc.
  • Capsulution Nanoscience AG
  • Celgene Corporation
  • Johnson & Johnson
  • Nanobiotix
  • Nanocarrier Co. Ltd.
  • Merck & Co. Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi SA
  • SkyePharma PLC
  • Starpharma Holdings Limited
  • Teva Pharmaceutical Industries Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Technology
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Nanotechnology Drug Delivery Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Nanotechnology Drug Delivery Market, By Technology, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Nanoparticles
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Nano suspensions
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Liposomes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Micelles
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Nanotechnology Drug Delivery Market, By Application, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oncology and Hematology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Infectious diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Orthopedics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Neurology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Urology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Immunology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Nanotechnology Drug Delivery Market, By End User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospitals & Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Biopharmaceutical Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Research Institutes & Laboratories
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Nanotechnology Drug Delivery Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • AbbVie Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Geistlich Pharma AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Alkermes plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AngioDynamics Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Arrowhead Pharmaceuticals Inc.
  • BIND Therapeutics Inc.
  • Capsulution Nanoscience AG
  • Celgene Corporation
  • Johnson & Johnson
  • Nanobiotix
  • Nanocarrier Co. Ltd.
  • Merck & Co. Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi SA
  • SkyePharma PLC
  • Starpharma Holdings Limited
  • Teva Pharmaceutical Industries Ltd.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. Reference and Research Methodology

• References
• Research Methodology
• About us and Sales Contact